Related content

International patent applications for non‐injectable naloxone for opioid overdose reversal: Exploratory search and retrieve analysis of the PatentScope database

By  

DRUG AND ALCOHOL REVIEW, Vol. 37, Iss. 2, 2018-02 ,pp. : 205-215

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities

By Coffin Phillip O.  

Journal of Medical Economics, Vol. 16, Iss. 8, 2013-08 ,pp. : 1051-1060

Informa Healthcare

Access to resources Recommend Favorite

Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond

By  

DRUG AND ALCOHOL REVIEW, Vol. 34, Iss. 4, 2015-07 ,pp. : 404-411

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early supported discharge after stroke

By Langhorne Peter   Widen-Holmqvist Lotta    

Journal of Rehabilitation Medicine, Vol. 39, Iss. 2, 2007-03 ,pp. : 103-108

Medical Journals Limited

Access to resources Recommend Favorite

Take-Home Emergency Naloxone to Prevent Heroin Overdose Deaths after Prison Release: Rationale and Practicalities for the N-ALIVE Randomized Trial

By Strang John   Bird Sheila   Parmar Mahesh  

Journal of Urban Health: Bulletin of the New York Academy of Medicine, Vol. 90, Iss. 5, 2013-10 ,pp. : 983-996

Springer Publishing Company

Access to resources Recommend Favorite